Search for content, post, videos

XNK Therapeutics appoints new CMO

XNK Therapeutics has announced the appointment of Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Hovstadius will be a member of the company’s management team.  Johan Aschan who retires from his position as CMO will continue as the company’s Senior Medical Advisor.
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.